Results of 2-year open multicenter observational study for efficacy, safety, tolerability and quality of life impact of zoledronic acid in women with postmenopausal osteoporosis in real-world settings in Russian Federation
O. M. Lesnyak,
O. N. Anoshenkova,
I. N. Barbarin,
G. Sh. Golubev,
L. P. Isaenko,
T. A. Knyazkova,
M. R. Nekrasova,
N. V. Nikitina,
L. B. Reznikova,
E. F. Semisotova,
A. N. Shandin
Affiliations
O. M. Lesnyak
ГБОУ ВПО СЗГМУ им. И. И. Мечникова МЗ РФ
O. N. Anoshenkova
ООО «МАКС и К», медицинский центр «Максимум Здоровья»
Effect of zoledronic acid on bone mineral density in women with postmenopausal osteoporosis was evaluated in 2-year open multicenter observational study in real-world settings in Russian Federation. These data confirmed efficacy and safety of zoledronic acid treatment which were previously shown in the international clinical trials.
